←Back to Expert Scholars
Translational Medicine / 转化医学Cancer Trials, Biomarker Trial Design
Lawrence V. Rubinstein
PhD
🏢National Cancer Institute🌐USA
Deputy Associate Director, Biometric Research Program
65
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Lawrence Rubinstein has led NCI biostatistical methodology work on phase II and biomarker-based oncology trial designs. His work has shaped the design and interpretation of cooperative group biomarker studies. He has authored influential papers on phase II design efficiency.
Share:
🧪Research Fields 研究领域
phase II design
biomarker trials
randomized discontinuation
biostatistics
NCI methodology
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Lawrence V. Rubinstein 的研究动态
Follow Lawrence V. Rubinstein's research updates
留下邮箱，当我们发布与 Lawrence V. Rubinstein（National Cancer Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment